Glomerular Microangiopathy with Cellular Crescent-like Formation and Endotheliopathy Due to Ramucirumab Treatment for Metastatic Sigmoid Colon Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Glomerular Microangiopathy with Cellular Crescent-like Formation and Endotheliopathy Due to Ramucirumab Treatment for Metastatic Sigmoid Colon Cancer

Published:2022-12-01 Issue:23 Volume:61 Page:3547-3552
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Yoshimura Yusuke¹,Sawa Naoki¹,Matsuoka Shusaku¹,Ikuma Daisuke¹,Oba Yuki¹,Sekine Akinari²,Hasegawa Eiko²,Mizuno Hiroki¹,Yamanouchi Masayuki¹,Suwabe Tatsuya¹,Hoshino Junichi¹,Kono Kei³,Kinowaki Keiichi³,Ohashi Kenichi⁴,Toda Shigeo⁵,Matoba Shuichiro⁵,Wakui Hideki⁶,Ubara Yoshifumi¹

Affiliation:

1. Nephrology Center, Toranomon Hospital Kajigaya, Japan

2. Nephrology Center, Toranomon Hospital, Japan

3. Department of Pathology, Toranomon Hospital, Japan

4. Department of Human Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan

5. Department of Gastroenterological Surgery, Toranomon Hospital, Japan

6. Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/61/23/61_9185-21/_pdf

Reference12 articles.

1. 1. Yamada R, Okawa T, Matsuo K, Suzuki M, Mori N, Mori K. Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report. BMC Nephrol 20: 14, 2019.

2. 2. Fujii T, Kawasoe K, Tonooka A, Ohta A, Nitta K. Nephrotic syndrome associated with ramucirumab therapy: a single-center case series and literature review. Medicine (Baltimore) 98: e16236, 2019.

3. 3. Ozawa M, Ohtani H, Komatsuda A, Wakui H, Takahashi N. VEGF-VEGFR2 inhibitor-associated hyaline occlusive glomerular microangiopathy: a Japanese single-center experience. Clin Exp Nephrol 25: 1193-1202, 2021.

4. 4. Nair R. Focal segmental glomerulosclerosis: cellular variant and beyond. Kidney Int 70: 1676-1678, 2006.

5. 5. Stokes MB, Valeri AM, Markowitz GS, D'Agati VD. Cellular focal segmental glomerulosclerosis: clinical and pathologic features. Kidney Int 70: 1783-1792, 2006.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A robust and validated LC–MS/MS method for the quantification of ramucirumab in rat and human serum using direct enzymatic digestion without immunoassay;Journal of Chromatography B;2024-02

2. Impact of prior bevacizumab therapy on the incidence of ramucirumab-induced proteinuria in colorectal cancer: a multi-institutional cohort study;International Journal of Clinical Oncology;2023-06-01

3. Antineoplastics/folinic acid;Reactions Weekly;2023-01-07

4. Determinants of the Pathological Features of Renal Adverse Effects Due to Vascular Endothelial Growth Factor Signaling Inhibition;Internal Medicine;2022-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3